Area of research
Oncology · Surgery
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Pancreatitis Pathology and Treatment, Esophageal Cancer Research and Treatment, and Cancer Immunotherapy and Biomarkers.
Human-Derived Proteome Characterization of Tongue Coating in Colorectal Cancer
Utilizing MXene-mediated electron transfer pathway to boost peroxymonosulfate activation for water purification
An open label, safety study of Asian patients with advanced non-small-cell lung cancer receiving second-line nivolumab monotherapy (CheckMate 870)
TLR4 regulatory region variants reduce the susceptibility of small-cell lung cancer in Chinese population
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer: 2-year follow-up from a randomized, open-label, phase 3 study (CheckMate 078)
Abstract CT218: Flat-dose nivolumab (NIVO) as second-line (2L) treatment (tx) for Asian patients (pts) with advanced non-small cell lung cancer (NSCLC): CheckMate 870
Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis
Significance of Combined Preoperative Serum ALB and DNLR For Diagnosis of Pancreatic Cancer
The Diagnostic Role of Circulating Inflammation-Based Biomarker in Gallbladder Carcinoma
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)